June 4, 2025
TOPLINE: Nearly 12% of individuals using preexposure prophylaxis (PrEP) for HIV prevention, were diagnosed with alcohol use disorder (AUD) within 6 months of initiating PrEP, whereas […]
May 28, 2025
TOPLINE: A recent study found that antiretroviral therapy adherence below 90% was associated with significantly lower odds of viral suppression among women living with HIV. METHODOLOGY: […]
May 23, 2025
The European Medicines Agency (EMA) has given a positive opinion to a generic medicine, emtricitabine/tenofovir alafenamide, for the treatment of adults and adolescents infected with HIV […]
May 14, 2025
Cuts to HIV programming are affecting local prevention programs across the United States, but the potential impacts on public health and healthcare costs are especially high […]
May 13, 2025
An artificial intelligence (AI) model using routinely collected data predicted subsequent development of active tuberculosis (TB), Swiss researchers reported. The AI model outperformed biological tests for […]
May 7, 2025
TOPLINE: Long-acting antiretroviral therapy (LA-ART) maintained high viral suppression for 48 weeks in patients with HIV regardless of initial viremia. METHODOLOGY: Researchers examined viral suppression for […]
May 6, 2025
TOPLINE: AIDS-related illnesses continued to be the leading cause of hospitalization, accounting for 42% of the admissions, with tuberculosis being the most frequent illness. This pattern […]
April 28, 2025
The legacy of discriminatory housing policies continues to shape both economic and health outcomes. A study by Tulane University, New Orleans, published in JAMA Internal Medicine, […]
April 23, 2025
TOPLINE: Long-acting injectable HIV treatment led to rectal shedding in nearly 15% of patients with HIV, independent of the oral lead-in phase. A high pretreatment viral […]